Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (60)
  • Agitation (1)
  • Anxiety (28)
  • Bipolar Disorder (14)
  • Depression (190)
    • Cardiovascular Disease and Depression (4)
    • Drugs (166)
      • Atypical Antipsychotics (51)
      • Benzodiazepines (33)
      • Bupropion (35)
      • MAOIs (10)
      • SNRIs (69)
      • SSRIs (91)
      • TCAs (34)
      • Typical Antipsychotics (2)
    • Natural Medicines/Supplements (9)
    • Pediatrics (13)
    • Post-Traumatic Stress Disorder (9)
    • Pregnancy (8)
    • Seasonal Affective Disorder (5)
    • Treatment-Resistant Depression (16)
  • Mental Health (26)
  • Resources (116)
  • Schizophrenia (46)
  • Sleep Disorders (75)
  • Substance Use Disorder (175)
151 - 165 of 166 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Practice Guideline for the Treatment of Patients With Major Depressive Disorder (2010) November 2010
Commentary: Depression Guidelines: Overview of Pharmacotherapy November 2010
Commentary: Oleptro (Trazodone) and Silenor (Doxepin) October 2010
Chart: State Regulations on Generic Substitution August 2010
Chart: Comparison of Venlafaxine and Desvenlafaxine August 2010
Chart: Follow-on Drugs: Therapeutic Benefit or Economic Burden? July 2009
Commentary: Nuvigil (Armodafinil) July 2009
Commentary: New Drug: Savella (Milnacipran) March 2009
Guideline: Management of fibromyalgia syndrome in adults (2009) March 2009
Commentary: New Venlafaxine Extended-Release Formulation January 2009
Other: New Venlafaxine Extended-Release Formulation January 2009
Commentary: Pristiq (Desvenlafaxine) May 2008
Chart: Authorized Generics Currently Available May 2008
Commentary: Time-release Generic Products:
Are They Equivalent To the Brand Product?
May 2008
Chart: Drug-induced Long QT Interval November 2007
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved